Gene · 162514
Papers1,367
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,367
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fragrant TRPV3 agonists act as titratable organic adjuvants to amplify antigen-specific IgG response. | Immun Inflamm | 2026 | 41797879 | PubTator, text mining | PubMed |
| Epidermal PAR2-TRPV3-IL-33 Signaling Promotes Mast Cell Recruitment and Sensory Nerve-Mast Cell Interactions in Atopic Dermatitis. | Allergy | 2026 | 41795617 | PubTator, text mining | PubMed |
| The ectopic olfactory receptor OR7A17 regulates the proliferation and differentiation of human epidermal keratinocytes, and ginsenoside Rh3 acts as its antagonist. | J Ginseng Res | 2026 | 41788573 | PubTator, text mining | PubMed |
| HaloTag-based approach to quantify subcellular localization of TRPV3 channels. | Biophys J | 2026 | 41787805 | PubTator, text mining | PubMed |
| Proteolytic dysregulation in the skin: insight from rare monogenic skin diseases. | Cell Tissue Res | 2026 | 41776113 | PubTator, text mining | PubMed |
| Special Issue "Cellular and Molecular Insights into Ocular Changes Associated with Systemic Disorders and Conditions". | Int J Mol Sci | 2026 | 41752160 | PubTator, text mining | PubMed |
| Differential Expression of Endocannabinoid Receptors in Lesional and Non-Lesional Skin of Psoriasis Patients: Insights Into Pathogenesis and Potential Therapeutic Targets. | J Cutan Med Surg | 2026 | 41699832 | PubTator, text mining | PubMed |
| Role of transient receptor potential channels on pathogenesis and treatment of psoriasis. | Inflammopharmacology | 2026 | 41689746 | PubTator, text mining | PubMed |
| Azelaic acid potentiates TRPV3 activity as a mechanism for skin irritation. | J Invest Dermatol | 2026 | 41644087 | PubTator, text mining | PubMed |
| Transient Receptor Potential (TRP) Channels as Fundamental Regulators of Fibrosis and Pruritus-A New Therapeutic Target for Pathological Scar Management. | Int J Mol Sci | 2026 | 41596464 | PubTator, text mining | PubMed |
| Characterization of the Functional Transient Receptor Potential Vanilloid Channels 1 to 4 in Human Corneal Endothelial Cells. | Invest Ophthalmol Vis Sci | 2026 | 41533920 | PubTator, text mining | PubMed |
| Activation of TRPV3 channels in bladder cancer cells stimulates ATP release. | Mol Pharmacol | 2026 | 41422779 | PubTator, text mining | PubMed |
| A new horizon for the anesthetic drug dyclonine. | Biochem Pharmacol | 2026 | 41318105 | PubTator, text mining | PubMed |
| Decreased Transient Receptor Potential Channel mRNA Expression in the Aortas of Patients with Hypertension. | Anatol J Cardiol | 2026 | 40454880 | PubTator, text mining | PubMed |
| Pathway-dependent cold activation of heat-responsive TRPV channels. | Sci Rep | 2025 | 41326491 | PubTator, text mining | PubMed |
| Brief topical application of TRPV3 channel agonist carvacrol mediates skin vasodilation via NOS, COX, and K+ channel pathways in young adults. | Eur J Pharmacol | 2025 | 41207353 | PubTator, text mining | PubMed |
| The Role of TRP Channels in Colitis and Inflammatory Bowel Disease: A Systematic Review. | Int J Mol Sci | 2025 | 41096659 | PubTator, text mining | PubMed |
| Deciphering conformational dynamics in AFM data using fast nonlinear NMA and FFT-based search with AFMFit. | Commun Biol | 2025 | 41023150 | PubTator, text mining | PubMed |
| Harnessing Protein Unfolding for Thermosensing: Structural Insights from TRPV3. | bioRxiv | 2025 | 41000676 | PubTator, text mining | PubMed |
| Determinants for Activation of the Ion Channel TRPV3 by Weak Acids. | Int J Mol Sci | 2025 | 40943198 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/162514/papers?page=2